Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Amgen is set to release its second-quarter earnings next month, and analysts are projecting modest single-digit growth in ...

Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an eight-week period.

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It March 17, 2025 — 09:00 am EDT. Written by Zacks Equity Research for ...